Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Receivables - Net: 2023-2024

Historic Receivables - Net for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $10.5 million.

  • Zhengye Biotechnology Holding's Receivables - Net was N/A to $5.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $10.5 million for FY2024, which is 20.24% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Receivables - Net stood at $10.5 million for FY2024, which was down 20.24% from $13.1 million recorded in FY2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Receivables - Net ranged from a high of $13.1 million in FY2023 and a low of $10.5 million during FY2024.